Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Y C Wong

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 19, 2006
Systemic targeted radionuclide therapy: potential new areasJeffrey Y C Wong
International Journal of Radiation Oncology, Biology, Physics|September 19, 2006
Basic immunology of antibody targeted radiotherapyJeffrey Y C Wong
Practical Radiation Oncology|April 18, 2020
Estimation of radiation-induced, organ-specific, secondary solid-tumor occurrence rates with total body irradiation and total marrow irradiation treatmentsChunhui Han, An Liu, Jeffrey Y C Wong
Frontiers in Oncology|August 12, 2022
Target Coverage and Normal Organ Sparing in Dose-Escalated Total Marrow and Lymphatic Irradiation: A Single-Institution ExperienceChunhui Han, An Liu, Jeffrey Y C Wong
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 5, 2011
Dosimetric study of volumetric modulated arc therapy fields for total marrow irradiationChunhui Han, Timothy E Schultheisss, Jeffrey Y C Wong
Practical Radiation Oncology|January 17, 2017
Estimation of radiation-induced secondary cancer risks for early-stage non-small cell lung cancer patients after stereotactic body radiation therapyChunhui Han, Timothy E Schultheiss, Jeffrey Y C Wong
Cancer Biotherapy & Radiopharmaceuticals|December 23, 2009
HDAC inhibitor, valproic acid, induces p53-dependent radiosensitization of colon cancer cellsXufeng Chen, Patty Wong, Eric Radany, et al.
International Journal of Radiation Oncology, Biology, Physics|March 22, 2008
Impact of drug therapy, radiation dose, and dose rate on renal toxicity following bone marrow transplantationJonathan C Cheng, Timothy E Schultheiss, Jeffrey Y C Wong
Frontiers in Oncology|January 23, 2023
Volumetric modulated arc therapy based total marrow and lymphoid irradiation: Workflow and clinical experienceColton Ladbury, Chunhui Han, An Liu, et al.
Molecular Cancer Research : MCR|February 10, 2011
Low-dose valproic acid enhances radiosensitivity of prostate cancer through acetylated p53-dependent modulation of mitochondrial membrane potential and apoptosisXufeng Chen, Jeffrey Y C Wong, Patty Wong, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|September 19, 2006
Systemic targeted radionuclide therapy: potential new areasJeffrey Y C Wong
International Journal of Radiation Oncology, Biology, Physics|September 19, 2006
Basic immunology of antibody targeted radiotherapyJeffrey Y C Wong
Practical Radiation Oncology|April 18, 2020
Estimation of radiation-induced, organ-specific, secondary solid-tumor occurrence rates with total body irradiation and total marrow irradiation treatmentsChunhui Han, An Liu, Jeffrey Y C Wong
Frontiers in Oncology|August 12, 2022
Target Coverage and Normal Organ Sparing in Dose-Escalated Total Marrow and Lymphatic Irradiation: A Single-Institution ExperienceChunhui Han, An Liu, Jeffrey Y C Wong
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 5, 2011
Dosimetric study of volumetric modulated arc therapy fields for total marrow irradiationChunhui Han, Timothy E Schultheisss, Jeffrey Y C Wong
Practical Radiation Oncology|January 17, 2017
Estimation of radiation-induced secondary cancer risks for early-stage non-small cell lung cancer patients after stereotactic body radiation therapyChunhui Han, Timothy E Schultheiss, Jeffrey Y C Wong
Cancer Biotherapy & Radiopharmaceuticals|December 23, 2009
HDAC inhibitor, valproic acid, induces p53-dependent radiosensitization of colon cancer cellsXufeng Chen, Patty Wong, Eric Radany, et al.
International Journal of Radiation Oncology, Biology, Physics|March 22, 2008
Impact of drug therapy, radiation dose, and dose rate on renal toxicity following bone marrow transplantationJonathan C Cheng, Timothy E Schultheiss, Jeffrey Y C Wong
Frontiers in Oncology|January 23, 2023
Volumetric modulated arc therapy based total marrow and lymphoid irradiation: Workflow and clinical experienceColton Ladbury, Chunhui Han, An Liu, et al.
Molecular Cancer Research : MCR|February 10, 2011
Low-dose valproic acid enhances radiosensitivity of prostate cancer through acetylated p53-dependent modulation of mitochondrial membrane potential and apoptosisXufeng Chen, Jeffrey Y C Wong, Patty Wong, et al.
Pageof 10